CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.

Barclays shares poised for more losses

The COVID-19 crisis continues to weigh on British banks, with Barclays share price poised for more losses despite its strong rally last month.

Barclays looks set to break lower, as the retreat from 110p goes on. Rising trendline support from the March low at 73p has allowed higher lows to form over the past eight weeks, but the current four day drop has now begun to test this line.

‘Since the rebound began in mid-March, the price has twice attempted to break above the 110p area,’ Chris Beauchamp, chief market analyst at IG said. ‘Both attempts have ended in failure, with the area remaining as resistance. The present move lower brings 85p and 80p into view, the previous higher lows on the way up.’

The reversal over the past four sessions looks like the downtrend is resuming, a view reinforced by the potential bearish crossover in the daily moving average convergence/divergence (MACD), something that has not happened since late February. To provide a more bullish view, the price needs to reverse and take out 100p, reclaiming the 50-day simple moving average (SMA) of 99p in the process.

RBC rates Barclays as ‘sector performer’

Analysts from RBC Capital Markets believe that Barclays will emerge from the COVID-19 crisis in a relatively healthy position, with the investment bank reiterating its ‘sector performer’ rating for the stock earlier this month.

RBC also gave a target price for Barclays of 110p, implying a 13.4% upside for the stock based on the lender closing at 97p per share on Thursday.

Barclays braces for COVID-19

The impact of COVID-19 crisis came quite late in to what had been a relatively good first quarter for Barclays. Statutory pre-tax profit came in at £900 million for the British lender, with pre-tax profit (excluding credit impairment charges) sitting at £3 billion for the quarter.

The bank allocated £2.1 billion credit impairment charge to offset the rise in bad loans driven by the coronavirus pandemic. But despite the economic fallout from the outbreak, Barclays management remains optimistic that the bank will successfully navigate the crisis.

‘Barclays is committed to supporting its customers, clients and the UK economy through the crisis,’ Barclays Group chief executive officer (CEO) Jes Staley said. Despite the macroeconomic downturn caused by the COVID-19 pandemic, the Group’s position remains robust, reflecting our diversified business model.’

How much does it cost to buy UK shares with IG?

There is one way to ‘buy’ UK shares with IG: trading CFDs. The cost will depend on which method you choose. The table below illustrates how the costs to get exposure to £10,000 of Lloyds stock, which is equivalent to 16,000 shares (quoted at 62.5p a share).

Remember, CFDs are derivatives, which come with higher risk and reward than investing.

Cost to get exposure to Lloyds stock

CFD trading
Action Buy 16,000 share CFDs
Capital required to open £2000
Total fees £20.88

Ready to start trading shares? Open a live account or practise on a demo.

This information has been prepared by IG, a trading name of IG Markets Ltd and IG Markets South Africa Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices
liveprices.javascriptrequired
liveprices.javascriptrequired
liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Monday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.